San Carlos, CA, United States of America

Reinhard König

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reinhard König. Retrieved from https://idiyas.com/inventor/reinhard-kandoumlnig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Reinhard König: Innovator in Thrombolytic Therapy

Introduction

Reinhard König is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of thrombolytic therapy, focusing on innovative methods to treat thromboembolic conditions. His work has the potential to improve patient outcomes in critical medical situations.

Latest Patents

König holds a patent titled "Method for treating thromboembolic conditions by inhibiting reocclusion via the use of multiple bolus administration of thrombolytically active proteins." This patent discusses therapeutic approaches that utilize thrombolytically active proteins to inhibit reocclusion in patients. The proteins are administered in two or more boli, enhancing the effectiveness of the treatment.

Career Highlights

Throughout his career, Reinhard König has been associated with Boehringer Mannheim GmbH, a company known for its advancements in medical technology and pharmaceuticals. His work at the company has allowed him to focus on developing innovative therapies that address complex medical challenges.

Collaborations

König has collaborated with various professionals in the field, including his coworker Ulrich Martin. These collaborations have fostered an environment of innovation and have contributed to the development of effective therapeutic solutions.

Conclusion

Reinhard König's contributions to thrombolytic therapy exemplify the impact of innovative thinking in medicine. His patent and work at Boehringer Mannheim GmbH highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…